Underweight, Overweight, and Linear Growth of Childhood Cancer Patients - the Growth Study (NCT07750444) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Underweight, Overweight, and Linear Growth of Childhood Cancer Patients - the Growth Study
Switzerland12,150 participantsStarted 2025-10-01
Plain-language summary
The Growth study investigates nutritional status, BMI, and linear growth trajectories from birth to adulthood in childhood cancer patients and survivors. Specifically, it aims to identify the predictors driving these distinct growth and weight trajectories and evaluate the consistency of these findings across multiple European countries.
The study will make use of routine collected clinical data from oncology centres. Additional information about diagnoses, treatments, sociodemographic, and lifestyle data are obtained by linkages with disease and population registries, and with previously conducted questionnaire studies among survivors.
The study will provide insights into the nutritional status of childhood cancer patients and survivors and improve understanding of growth patterns in this population.
Who can participate
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
. Switzerland: patients who visited one of the cancer centres in Switzerland: Aarau, Basel, Bellinzona, Bern, Geneva, Lausanne, Lucerne, St. Gallen, Zurich.
. Portugal: patients diagnosed between 2012-2026 at the Portuguese paediatric oncology centres Instituto Português de Oncologia do Porto Francisco Gentil - IPO-PORTO or at the Instituto Português de Oncologia Francisco Gentil - IPOLFG.
. Slovenia: patients diagnosed between 2011-2026 at the paediatric oncology clinic University Medical Center Ljubljana.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Body Mass Index z-score, Height z-score, Weight z-score
Timeframe: Through study completion, an expected average of 20 years